Avitar, Inc. (AVTI)

Market Cap	731.00
Revenue (ttm)	2.66M
Net Income (ttm)	-2.80M
Shares Out	731.31M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Average Volume	51,507
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-64.76
RSI	35.40
Earnings Date	n/a

About Avitar

Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 36
• Stock Exchange: OTCMKTS
• Ticker Symbol: AVTI

Financial Performance

In 2007, Avitar's revenue was $3.11 million, a decrease of -31.26% compared to the previous year's $4.52 million. Losses were -$2.41 million, -37.61% less than in 2006.